Janus Henderson Group PLC Harmony Biosciences Holdings, Inc. Transaction History

Janus Henderson Group PLC

  • $194 Billion
  • Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 16,402 shares of HRMY stock, worth $468,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,402
Previous 144,727 88.67%
Holding current value
$468,605
Previous $4.8 Million 89.22%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$27.94 - $35.91 $3.59 Million - $4.61 Million
-128,325 Reduced 88.67%
16,402 $518,000
Q1 2025

May 15, 2025
SELL
$32.18 - $40.46 $2.46 Million - $3.09 Million
-76,336 Reduced 34.53%
144,727 $4.8 Million
Q4 2024

Feb 14, 2025
BUY
$31.86 - $41.49 $1.67 Million - $2.18 Million
52,563 Added 31.19%
221,063 $7.61 Million
Q3 2024

Nov 14, 2024
SELL
$30.0 - $39.95 $296,010 - $394,186
-9,867 Reduced 5.53%
168,500 $6.73 Million
Q2 2024

Aug 14, 2024
SELL
$28.81 - $33.01 $193,487 - $221,695
-6,716 Reduced 3.63%
178,367 $5.38 Million
Q1 2024

May 15, 2024
BUY
$29.93 - $35.06 $5.04 Million - $5.91 Million
168,434 Added 1011.68%
185,083 $6.22 Million
Q4 2023

Feb 14, 2024
SELL
$19.2 - $33.78 $787 - $1,384
-41 Reduced 0.25%
16,649 $537,000
Q3 2023

Nov 14, 2023
BUY
$31.89 - $39.03 $127 - $156
4 Added 0.02%
16,690 $546,000
Q2 2023

Aug 14, 2023
SELL
$30.5 - $37.4 $1.06 Million - $1.3 Million
-34,691 Reduced 67.52%
16,686 $587,000
Q1 2023

May 15, 2023
SELL
$30.8 - $53.92 $38.2 Million - $66.9 Million
-1,240,758 Reduced 96.02%
51,377 $1.68 Million
Q4 2022

Feb 14, 2023
SELL
$45.4 - $60.91 $10.1 Million - $13.6 Million
-222,968 Reduced 14.72%
1,292,135 $71.2 Million
Q3 2022

Nov 14, 2022
BUY
$42.06 - $55.45 $3.78 Million - $4.99 Million
89,935 Added 6.31%
1,515,103 $67.1 Million
Q2 2022

Aug 15, 2022
SELL
$33.54 - $52.15 $6.03 Million - $9.37 Million
-179,741 Reduced 11.2%
1,425,168 $69.5 Million
Q1 2022

May 16, 2022
BUY
$33.14 - $51.13 $2.03 Million - $3.13 Million
61,185 Added 3.96%
1,604,909 $78.1 Million
Q4 2021

Feb 14, 2022
BUY
$34.09 - $43.91 $11.1 Million - $14.2 Million
324,165 Added 26.58%
1,543,724 $65.8 Million
Q3 2021

Nov 16, 2021
SELL
$25.68 - $38.61 $1.07 Million - $1.62 Million
-41,833 Reduced 3.32%
1,219,559 $46.7 Million
Q2 2021

Aug 16, 2021
BUY
$25.96 - $33.44 $2.79 Million - $3.6 Million
107,609 Added 9.33%
1,261,392 $35.6 Million
Q1 2021

May 17, 2021
BUY
$27.56 - $40.37 $1.64 Million - $2.4 Million
59,334 Added 5.42%
1,153,783 $38.1 Million
Q4 2020

Feb 16, 2021
BUY
$31.74 - $51.34 $6.97 Million - $11.3 Million
219,540 Added 25.09%
1,094,449 $39.6 Million
Q3 2020

Nov 16, 2020
BUY
$30.96 - $44.39 $27.1 Million - $38.8 Million
874,909 New
874,909 $29.7 Million

Others Institutions Holding HRMY

# of Institutions
291
Shares Held
46.3M
Call Options Held
316K
Put Options Held
69.9K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.69B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email